Literature DB >> 1440628

Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. BIASG (Butantan Institute Antivenom Study Group).

G D Laing1, R D Theakston, R P Leite, W D da Silva, D A Warrell.   

Abstract

Three Brazilian polyspecific Bothrops antivenoms were compared using standard W.H.O. rodent in vivo and in vitro assays of their ability to neutralize the principal venom activities of pooled whole Bothrops jararaca venom. On a volume basis, the antivenoms were equally effective in neutralizing lethal activity in mice, and there were only minor differences in their ability to neutralize venom-induced haemorrhage, necrosis and procoagulant activity. Antivenom efficacy in neutralizing defibrinogenation varied. However, when equal amounts of antivenom IgG were compared, it was found that the FUNED antivenom best neutralized lethality, haemorrhage, necrosis and fibrinogen clotting activity. Vital Brazil and FUNED antivenoms were equally effective in neutralizing plasma coagulant activity but Vital Brazil antivenom was the more effective in neutralizing defibrinogenation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1440628     DOI: 10.1016/0041-0101(92)90438-b

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom.

Authors:  R A Harrison; A M Moura-Da-Silva; G D Laing; Y Wu; A Richards; A Broadhead; A E Bianco; R D Theakston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom.

Authors:  R G Jones; L Lee; J Landon
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

Review 4.  Diagnosis of snakebite and the importance of immunological tests in venom research.

Authors:  R David G Theakston; Gavin D Laing
Journal:  Toxins (Basel)       Date:  2014-05-23       Impact factor: 4.546

5.  Antitoxin activity of aqueous extract of Cyclea peltata root against Naja naja venom.

Authors:  Thulasi Sivaraman; N S Sreedevi; S Meenatchisundaram; R Vadivelan
Journal:  Indian J Pharmacol       Date:  2017 Jul-Aug       Impact factor: 1.200

6.  The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms.

Authors:  Stuart Ainsworth; Julien Slagboom; Nessrin Alomran; Davinia Pla; Yasir Alhamdi; Sarah I King; Fiona M S Bolton; José María Gutiérrez; Freek J Vonk; Cheng-Hock Toh; Juan J Calvete; Jeroen Kool; Robert A Harrison; Nicholas R Casewell
Journal:  Commun Biol       Date:  2018-04-19

7.  Factor XII-Deficient Chicken Plasma as a Useful Target for Screening of Pro- and Anticoagulant Animal Venom Toxins.

Authors:  Benedito C Prezoto; Nancy Oguiura
Journal:  Toxins (Basel)       Date:  2020-01-23       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.